Cartherics, a biotechnology company developing off-the-shelf immune stem cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, has unveiled its new cleanroom facility for clinical-scale manufacturing of cell therapy products. The facility wa
AbbVie has announced that it has received marketing authorisation from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ELAHERE (mirvetuximab soravtansine) as monotherapy for the treatment of eligible adult patients with folate receptor-alpha (FRα) positive, platinum-resistant h
Plexāā, a MedTech startup behind the award-winning BLOOM⁴³ medical device for breast surgery, has announced the close of a 4.5 million USD funding extension round. The strategic capital infusion will support the imminent U.S. launch of BLOOM⁴³, while also laying the groundwork for future innovations
In a strategic move to improve patient outcomes in breast cancer, Affidea, a leading pan-European provider of community-based polyclinics, specialist services and advanced diagnostics, has announced that it has selected b-rayZ, a leader in AI-powered breast imaging solutions, as its preferred AI par
Backed by $4.6M in seed funding, Juniper is looking to define a new clinical standard of care for IVF genetic testing Juniper Genomics, a healthtech company pioneering a new standard of care in IVF, has announced its public launch alongside a 4.6 million USD seed round led by Company Ventures, with
The Medicines and Healthcare products Regulatory Agency (MHRA) has become the first regulator in the world to approve elinzanetant (Lynkuet) for the treatment of moderate to severe vasomotor symptoms (hot flushes) associated with the menopause. When oestrogen levels drop during menopause, certain br
ASPIVIX has announced a new partnership with AGHealth to launch Carevix, its MHRA-approved non-traumatic suction cervical stabiliser, in the United Kingdom. The company says this milestone marks a significant advance in UK women’s healthcare, offering a modern and clinically validated alternative to
Camgenium, a leading medical device software company, has announced that its software product, ‘Reassure Pregnancy’, can improve outcomes for pregnant women at risk of pre-eclampsia through at-home monitoring. The Reassure Pregnancy system allows women to proactively monitor their symptoms at home u
A new point of care test for pre-eclampsia is set to revolutionise testing for suspected pre-eclampsia in maternity units across the UK, aiding early detection and prognosis in pregnant women between 20-37 weeks of gestation. Placental growth factor (PLGF) was first recommended by NICE in 2016 for u
Inne, a healthtech startup empowering women to understand their reproductive health, has ‘broken through decades of stagnation’ in women’s health and become what it says is the first new tech-enabled contraception to receive certification in the UK and Europe with its Minilab saliva test device. Fol
FemTech, the sector focused on technology-driven women’s health solutions, is experiencing rapid growth. However, unique challenges exist in research, development, and innovation within this space. Sarah Bandy, assistant research and development manager and Kanika Mishra-Pathak, tax director at MHA
